Alaunos Therapeutics, Inc. SEC Filing Summary
2026-10-08SEC Filing 4 (0001193125-26-417970)
Holger Weis, CEO of Alaunos Therapeutics, Inc., acquired 23,564 shares of common stock on October 6, 2026. These shares were issued in lieu of net salary, with a transaction price of $0.7444 per share. Following this transaction, Mr. Weis now owns 49,047 shares of common stock directly.